10
Total investments
3
Early stage
2
Mid stage
0
Late stage
33y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Dec 2017
HelixNano is building the worlds most advanced mRNA platform to enable previously impossible applications across human and non-human biology
Angel Investor
Apr 2015
#1 Thrift Store for the Whole Family!
Moms Agree- Bargains SO BIG, unbeatable selection & brands! 20K+ Brands, 25K+ New Items Added Daily. SWAP BIG Bargains Make Big Planet Impact.
SHOP Now. Find Your SWAP Bargain JOY
Angel Investor
Jun 2014
Cobalt is the pioneer in pentesting as a service and a leader in offensive security services. We are focused on combining talent and technology with speed, scalability, and expertise. Thousands of customers and hundreds of partners rely on the Cobalt Offensive Security Platform, along with 500+ trusted pentesters, to find and fix vulnerabilities across their environments. By enabling faster pentest launches, real-time collaboration with pentesters, and seamless integration with remediation workflows, we help organizations identify critical issues and accelerate risk mitigation so they can operate fearlessly and innovate securely.
Angel Investor
Apr 2014
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.
Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential.
Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful.
Follow us on Twitter: twitter.com/cytovale
Subscribe to our newsletter: http://eepurl.com/huCdiH
H
Angel Investor
Jun 2013
HealthCrowd is the first truly unified SaaS platform for healthcare communications. By fusing healthcare domain expertise with ad analytics and machine learning, we help healthcare organizations communicate digitally with consumers to deliver business outcomes, both clinical and financial. Our approach is prescriptive and based on data. We are always improving, optimizing and innovating. In the rapidly changing world of healthcare, we stay ahead of the curve with technology, service excellence and pride of ownership. HealthCrowd is located in San Mateo, CA and is venture-backed. We are growing fast and excitedly looking to add one-of-a-kind team members to further propel us forward!
HealthCrowd is proud to be an equal opportunity workplace. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.
Angel Investor
Sep 2006
The decentralized business infrastructure of tomorrow will be based on fast 5G connectivity and multi-access edge clouds that process data using Artificial Intelligence.
FusionLayer provides patented Network Source of Truth and IP addressing solutions that lay out the automation bedrock for the network functions, intelligent devices, and business applications that connect through the next-generation edge clouds.
The future of networks is here.
At scale. With ease.
www.fusionlayer.com
Experience · 11 entries
All (11)
Investments (10)
Founder (1)
2025
2017
Angel Investor
Dec 2017
HelixNano is building the worlds most advanced mRNA platform to enable previously impossible applications across human and non-human biology
2015
Angel Investor
Apr 2015
#1 Thrift Store for the Whole Family!
Moms Agree- Bargains SO BIG, unbeatable selection & brands! 20K+ Brands, 25K+ New Items Added Daily. SWAP BIG Bargains Make Big Planet Impact.
SHOP Now. Find Your SWAP Bargain JOY
2014
Angel Investor
Jun 2014
Cobalt is the pioneer in pentesting as a service and a leader in offensive security services. We are focused on combining talent and technology with speed, scalability, and expertise. Thousands of customers and hundreds of partners rely on the Cobalt Offensive Security Platform, along with 500+ trusted pentesters, to find and fix vulnerabilities across their environments. By enabling faster pentest launches, real-time collaboration with pentesters, and seamless integration with remediation workflows, we help organizations identify critical issues and accelerate risk mitigation so they can operate fearlessly and innovate securely.
Angel Investor
Apr 2014
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.
Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential.
Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful.
Follow us on Twitter: twitter.com/cytovale
Subscribe to our newsletter: http://eepurl.com/huCdiH
Show all 11 entries ↓
Investment activity
1993–2025 · 10 investments
Recent (last 2 years)Earlier
